Search Results - Daniel Lysák

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Randomized Trial of Valganciclovir Versus Valacyclovir Prophylaxis for Prevention of Cytomegalovirus in Renal Transplantation

    Randomized Trial of Valganciclovir Versus Valacyclovir Prophylaxis for Prevention of Cytomegalovirus in Renal Transplantation by Tomáš Reischig, Martin Kacer, Pavel Jindra, Ondřej Hes, Daniel Lysák, Mirko Bouda

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patients

    TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patients by Jana Raková, Iva Truxová, Peter Holíček, Cyril Šálek, Michal Hensler, Lenka Kašíková, Josef Pasulka, Monika Holubová, Marek Kovář, Daniel Lysák, Justin Kline, Zdeněk Ráčil, Lorenzo Galluzzi, Radek Špíšek, Jitka Fučíková

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Calreticulin exposure on malignant blasts correlates with improved natural killer cell-mediated cytotoxicity in acute myeloid leukemia patients

    Calreticulin exposure on malignant blasts correlates with improved natural killer cell-mediated cytotoxicity in acute myeloid leukemia patients by Iva Truxová, Lenka Kašíková, Cyril Šálek, Michal Hensler, Daniel Lysák, Peter Holíček, Pavla Bílková, Monika Holubová, Xiufen Chen, Romana Mikyšková, Milan Reiniš, Marek Kovář, Barbora Tomalová, Justin Kline, Lorenzo Galluzzi, Radek Špíšek, Jitka Fučíková

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia

    Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment... by Hagop M. Kantarjian, Xavier Thomas, Anna Dmoszyńska, Agnieszka Wierzbowska, Grzegorz Mazur, Jiří Mayer, Jyh-Pyng Gau, Wen‐Chien Chou, Rena Buckstein, Jaroslav Čermák, Ching-Yuan Kuo, Albert Oriol, Farhad Ravandi, Stefan Faderl, Jacques Delaunay, Daniel Lysák, Mark D. Minden, Christopher Arthur

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Acalabrutinib Versus Investigator’s Choice in Relapsed/Refractory Chronic Lymphocytic Leukemia: Final ASCEND Trial Results

    Acalabrutinib Versus Investigator’s Choice in Relapsed/Refractory Chronic Lymphocytic Leukemia: Final ASCEND Trial Results by Paolo Ghia, Andrzej Pluta, Małgorzata Wach, Daniel Lysák, Martin Šimkovič, Iryna Kriachok, Árpád Illés, Javier de la Serna, Sean Dolan, Philip Campbell, Gerardo Musuraca, Abraham Jacob, Eric J. Avery, Jae Hoon Lee, Ganna Usenko, Min Hui Wang, Ting Yu, Wojciech Jurczak

    Published 2022
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients

    Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients by Peter Holíček, Iva Truxová, Jana Raková, Cyril Šálek, Michal Hensler, Marek Kovář, Milan Reiniš, Romana Mikyšková, Josef Pasulka, Šárka Vošáhlíková, Hana Remešová, Iva Valentová, Daniel Lysák, Monika Holubová, Petr Kašpar, Jan Procházka, Lenka Kašíková, Radek Špíšek, Lorenzo Galluzzi, Jitka Fučíková

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    ASCEND: Phase III, Randomized Trial of Acalabrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia

    ASCEND: Phase III, Randomized Trial of Acalabrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia by Paolo Ghia, Andrzej Pluta, Małgorzata Wach, Daniel Lysák, Tomáš Kozák, Martin Šimkovič, Polina Kaplan, Iryna Kraychok, Árpád Illés, Javier de la Serna, Sean Dolan, Phillip L. Campbell, Gerardo Musuraca, Abraham Jacob, Eric J. Avery, Jae Hoon Lee, Wei Liang, Priti Patel, Cheng S. Quah, Wojciech Jurczak

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: